From October 1, 2022 to December 31, 2022, the company has repurchased 950,400 shares, representing 0.24% for CNY 22.16 million. With this, the company has completed the repurchase of 3,531,226 shares, representing 0.89% for CNY 99.97 million under the buyback announced on February 14, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.4 CNY | +0.60% | -1.23% | -16.29% |
May. 24 | Amoy Diagnostics Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 30 May 2024 | CI |
May. 14 | Amoy Diagnostics Co., Ltd. Approves Final Cash Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.29% | 1B | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- 300685 Stock
- News Amoy Diagnostics Co., Ltd.
- Tranche Update on Amoy Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 14, 2022.